Literature DB >> 26656731

Patterns of lymph node metastasis of parotid cancer.

Hitomi Shinomiya1, Naoki Otsuki2, Daisuke Yamashita2, Ken-Ichi Nibu2.   

Abstract

OBJECTIVE: To define the incidence and pattern of spread of lymph node metastasis from parotid cancers and to clarify the risk factors and appropriate extent of neck dissection (ND) for individual patient with parotid cancer.
METHODS: A total of 72 patients with parotid gland cancer treated by surgery between 1994 and 2013 were analyzed retrospectively by reference to medical records. In line with our protocol, patients with clinically positive lymph nodes and/or cT3/T4 disease were generally selected to undergo ND.
RESULTS: Pathological examinations revealed mucoepidermoid carcinoma in 23 patients, carcinoma ex pleomorphic adenoma in 11, adenoid cystic carcinoma in 9, salivary duct carcinoma in 9, acinic cell carcinoma in 8, squamous cell carcinoma in 5, adenocarcinoma NOS in 4, epithelial myoepithelial carcinoma in 2, and basal cell carcinoma in 1. Thirty-three patients underwent neck dissection: modified radical ND (MRND) in 13, and elective ND (END) in 20. Postoperative RT (PORT) was performed in 33 patients. Among 13 cN+ patients, 10 were pN+ and lymph node metastasis was distributed mainly in levels I, II, III and V. Among 59 cN- patients, clinical T1, T2, T3 and T4 classifications accounted for 10, 24, 10 and 15 patients, respectively. The incidence of occult lymph node metastasis was 22%. Occult lymph node metastasis was mostly seen in the intraparotid, levels I and II of patients with cT4 disease. Among the ND group, 12 necks were pathologically negative for cancer (pN0). Relapse of neck lymph node metastasis occurred only in two patients treated by MRND with pathologically positive lymph nodes (pN+). These patients developed local and distant metastasis within 1 year after neck lymph node recurrence, and subsequently died of the cancer. pN+ was found in 19/30 high grade (63%), 1/10 intermediate grade (10%), and 3/32 low grade (9.4%). Among 33 patients who received PORT, only 1 patient relapsed neck lymph node.
CONCLUSION: For patients with clinically positive lymph nodes, ipsilateral modified radical neck dissection (levels I-V) is recommended. Elective neck dissection is strongly recommended for patients with T3N0 or T4N0 disease, and the extent of ND should include at least level I/II. PORT for patients with high-risk features may improve the outcome of good neck control.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Elective neck dissection; Lymph node metastasis; Modified radical neck dissection; Parotid cancer; Prognostic factor; Salivary gland carcinoma

Mesh:

Year:  2015        PMID: 26656731     DOI: 10.1016/j.anl.2015.11.002

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  8 in total

1.  Reoperation following the use of non-standardized procedures for malignant parotid tumors.

Authors:  Xiangmin Zhang; Xiangfu Zeng; Xiaolin Lan; Jing Huang; Keqing Luo; Keqiang Tian; Xiuhong Wu; Fufu Xiao; Shaojin Li
Journal:  Oncol Lett       Date:  2017-09-21       Impact factor: 2.967

2.  UM-HACC-2A: MYB-NFIB fusion-positive human adenoid cystic carcinoma cell line.

Authors:  Kristy A Warner; Alexandra E Oklejas; Alexander T Pearson; Zhaocheng Zhang; Weishing Wu; Vasu Divi; Christie Rodriguez-Ramirez; Rogerio M Castilho; Peter J Polverini; Jacques E Nör
Journal:  Oral Oncol       Date:  2018-10-18       Impact factor: 5.337

3.  A retrospective study of parotid gland tumors at a single institution.

Authors:  Shiori Suzuki; Nobuyuki Bandoh; Takashi Goto; Akinobu Kubota; Akihiro Uemura; Michihisa Kono; Ryosuke Sato; Ryuhei Takeda; Shota Sakaue; Tomomi Yamaguchi-Isochi; Hiroshi Nishihara; Hidehiro Takei; Yasuaki Harabuchi
Journal:  Oncol Lett       Date:  2022-05-13       Impact factor: 3.111

4.  Primary parotid carcinoma: analysis of risk factors and validation of a prognostic index.

Authors:  Alberto Paderno; Michele Tomasoni; Davide Mattavelli; Simonetta Battocchio; Davide Lombardi; Piero Nicolai
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-09-12       Impact factor: 2.503

5.  Probability and pattern of occult cervical lymph node metastases in primary parotid carcinoma.

Authors:  Dominik Stodulski; Bogusław Mikaszewski; Hanna Majewska; Piotr Wiśniewski; Czesław Stankiewicz
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-11-28       Impact factor: 2.503

6.  Role of the pretreatment neutrophil-to-lymphocyte ratio in the survival of primary parotid cancer patients.

Authors:  Guangyan Cheng; Fei Liu; Xinyu Niu; Qigen Fang
Journal:  Cancer Manag Res       Date:  2019-03-21       Impact factor: 3.989

7.  Evaluation of Prognostic Factors for the Parotid Cancer Treated With Surgery and Postoperative Radiotherapy.

Authors:  Yong-Hyub Kim; Woong-Ki Chung; Jae-Uk Jeong; Ick Joon Cho; Mee Sun Yoon; Ju-Young Song; Taek-Keun Nam; Sung-Ja Ahn; Dong Hoon Lee; Tae Mi Yoon; Joon Kyoo Lee; Sang Chul Lim
Journal:  Clin Exp Otorhinolaryngol       Date:  2019-09-05       Impact factor: 3.372

8.  Role of intraparotid node metastasis in mucoepidermoid carcinoma of the parotid gland.

Authors:  Xingyu Niu; Qigen Fang; Fei Liu
Journal:  BMC Cancer       Date:  2019-05-03       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.